To date, there have been no Invokana lawsuit settlements. We will continue to update this page, as well as the Invokana News section of our website, with breaking developments.
Along with other “SGLT2 inhibitors” like Jardiance and Farxiga, Janssen Pharmaceutical’s type 2 diabetes drug Invokana has been linked to ketoacidosis, a potentially fatal medical condition. In a recent US Food & Drug Administration Safety Communication, the agency cautioned current Invokana patients to watch for symptoms of severe blood acid poisoning.
As a result, many patients are considering filing lawsuits against Janssen. Claims are also being considered in relation to kidney failure and cardiovascular complications, including stroke and heart attack.
The experienced plaintiffs’ attorneys at Banville Law have begun to investigate the claims of patients who believe that Invokana, Jardiance, Farxiga or any other SGLT2 inhibitor led to ketoacidosis, kidney failure, heart attack or stroke. Our lawyers are devoted to providing compassionate representation to all injured patients nationwide. That’s why we offer a free, no obligation consultation, and always work on a contingency-fee basis. You owe us nothing until we secure a jury verdict or settlement in your favor.
For a free case eligibility evaluation, call Banville Law today.
How Settlements Work
With as many as 2 million Invokana prescriptions written every year, and the drug’s significant risks now accepted by the FDA, our attorneys believe that a number of claims will be filed against Janssen Pharmaceutical, the drug’s manufacturer and a subsidiary of Johnson & Johnson.
While many sources have reported that SGLT2 inhibitor claims have already been filed, the attorneys at Banville Law do not believe that to be the case.
Our attorneys expect the Invokana litigation to take the form of “multidistrict litigation,” or MDL. MDL comes into play when a high volume of lawsuits are expected, all of which share similar allegations against the same defendant.
Initial claims have been 0filed as individual personal injury lawsuits. If the number grows quickly, it’s possible that many of these individual claims will be “consolidated,” transferred to a single federal court under the guidance of a single judge.
After “discovery,” in which the two sides of a dispute obtain evidence from one another, and other pre-trial proceedings, the claims can be “remanded,” sent back to the courts in which they were initially filed. During consolidation, the questions of fact that all claims in an MDL have in common can be decided on simultaneously. Afterward, each individual plaintiff can decide for themselves whether or not to proceed to trial or accept a settlement offer.
In a “class action” on the other hand, plaintiffs are generally not afforded complete control over the outcome of their case.
Why Settlements Happen
Generally, settlements only become a possibility after several cases have proceeded to trial.
Once these initial, “bellwether” cases proceed to trial, and verdicts have been rendered in favor of plaintiffs, many of the other claims may result in a settlement.
In a settlement agreement, plaintiff and defendant will come together to determine a mutually acceptable amount of compensation. Settlement agreements can be entered before a trial has begun, or during its proceedings.
Large corporations often decide to settle claims, rather than proceed to trial, in order to reduce court and defense costs. Settlements can also limit a drug company’s exposure to media scrutiny.
Should I Wait To Contact An Attorney?
Each state has a statute of limitations, limiting the amount of time in which an injured patient can file suit. Even in the event that Invokana settlements do occur, patients who opt to wait for more lawsuits to be filed may lose the right to file their own.
Banville Law’s attorneys are here to answer your questions about the potential Invokana litigation. Contact us today for a free case evaluation.